Megha Mehrotra

2.1k citations
35 papers · 558 indexed · h-index 14

Megha Mehrotra

33 papers receiving 554 citations

Peers

Megha Mehrotra
Comparison fields: 5 of 74
  • Virology 141
  • Infectious Diseases 458
  • Epidemiology 285
  • General Health Professions 107
  • Family Practice 8
Replace Risha Irvin with:
Risha Irvin United States
Daniel R. B. Bezerra Brazil
Michael Kharfen United States
Lina Nerlander United States
Freddie Kibengo Uganda
John Weiser United States
José M Zuniga United States
Neal Carnes United States
Timothy R. Muwonge Uganda
Megha Mehrotra relative to Risha Irvin United States Risha Irvin's profile →
Citations per field
00.5×1.5×2.4×
Risha Irvin · 1×
Citations per year

Countries citing papers authored by Megha Mehrotra

Since Specialization
Citations

This map shows the geographic impact of Megha Mehrotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megha Mehrotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megha Mehrotra more than expected).

Fields of papers citing papers by Megha Mehrotra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megha Mehrotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megha Mehrotra. The network helps show where Megha Mehrotra may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Megha Mehrotra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Megha Mehrotra Line = papers co-authored together Megha Mehrotra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20240
3 20242
4 20242
5 20231
6 202313
7 202217
8 202210
9 20218
10 201911
11 201928
12 201832
13 201820
14 201630
15 201639
16 20151
17 201533
18 20159
19 20146
20 201457

About Megha Mehrotra

Megha Mehrotra is a scholar working on Virology, Infectious Diseases and Family Practice, having authored 35 papers that have together received 558 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (22 papers), HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (10 papers), HIV, Drug Use, Sexual Risk (9 papers), SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (4 papers), HIV-related health complications and treatments (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Virology (141 citations), Infectious Diseases (458 citations) and Epidemiology (285 citations). Megha Mehrotra has collaborated with scholars based in United States, Peru and Brazil. Frequent co-authors include Robert M. Grant, David V. Glidden, Vanessa McMahan, K. Rivet Amico, Patricia Defechereux, Juan V. Guanira, Valdiléa G. Veloso, Peter L. Anderson, J. Carlo Hojilla and Vivian I. Avelino‐Silva. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS and Behavior, The Journal of Infectious Diseases, Open Forum Infectious Diseases and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026